Genesys International Corporation Limited (NSE:GENESYS)

Kronos Bio Statistics

Total Valuation

NSE:GENESYS has a market cap or net worth of INR 24.30 billion. The enterprise value is 25.36 billion.

Market Cap	24.30B
Enterprise Value	25.36B

Important Dates

The next estimated earnings date is Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	41.68M
Shares Outstanding	n/a
Shares Change (YoY)	+4.24%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	19.06M

Valuation Ratios

The trailing PE ratio is 43.22.

PE Ratio	43.22
Forward PE	n/a
PS Ratio	7.81
PB Ratio	4.36
P/TBV Ratio	7.12
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.84, with an EV/FCF ratio of -26.33.

EV / Earnings	45.11
EV / Sales	8.15
EV / EBITDA	17.84
EV / EBIT	29.12
EV / FCF	-26.33

Financial Position

The company has a current ratio of 2.41, with a Debt / Equity ratio of 0.22.

Current Ratio	2.41
Quick Ratio	1.27
Debt / Equity	0.22
Debt / EBITDA	0.86
Debt / FCF	-1.27
Interest Coverage	9.92

Financial Efficiency

Return on equity (ROE) is 10.71% and return on invested capital (ROIC) is 8.86%.

Return on Equity (ROE)	10.71%
Return on Assets (ROA)	7.71%
Return on Invested Capital (ROIC)	8.86%
Return on Capital Employed (ROCE)	14.79%
Revenue Per Employee	3.14M
Profits Per Employee	567,338
Employee Count	991
Asset Turnover	0.44
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:GENESYS has paid 265.73 million in taxes.

Income Tax	265.73M
Effective Tax Rate	32.14%

Stock Price Statistics

The stock price has decreased by -18.51% in the last 52 weeks. The beta is -0.78, so NSE:GENESYS's price volatility has been lower than the market average.

Beta (5Y)	-0.78
52-Week Price Change	-18.51%
50-Day Moving Average	655.15
200-Day Moving Average	759.34
Relative Strength Index (RSI)	33.11
Average Volume (20 Days)	177,236

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:GENESYS had revenue of INR 3.11 billion and earned 562.23 million in profits. Earnings per share was 14.03.

Revenue	3.11B
Gross Profit	1.69B
Operating Income	871.01M
Pretax Income	826.76M
Net Income	562.23M
EBITDA	1.42B
EBIT	871.01M
Earnings Per Share (EPS)	14.03

Balance Sheet

The company has 179.11 million in cash and 1.22 billion in debt, giving a net cash position of -1.04 billion.

Cash & Cash Equivalents	179.11M
Total Debt	1.22B
Net Cash	-1.04B
Net Cash Per Share	n/a
Equity (Book Value)	5.57B
Book Value Per Share	139.86
Working Capital	2.66B

Cash Flow

In the last 12 months, operating cash flow was -528.58 million and capital expenditures -434.58 million, giving a free cash flow of -963.16 million.

Operating Cash Flow	-528.58M
Capital Expenditures	-434.58M
Free Cash Flow	-963.16M
FCF Per Share	n/a

Margins

Gross margin is 54.47%, with operating and profit margins of 28.00% and 18.08%.

Gross Margin	54.47%
Operating Margin	28.00%
Pretax Margin	26.58%
Profit Margin	18.08%
EBITDA Margin	45.70%
EBIT Margin	28.00%
FCF Margin	n/a

Dividends & Yields

NSE:GENESYS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.24%
Shareholder Yield	n/a
Earnings Yield	2.31%
FCF Yield	-3.96%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 23, 2010. It was a forward split with a ratio of 2.

Last Split Date	Jun 23, 2010
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	5